(Q36758590)

16 August 2017

1 reference

title

Emerging drugs in neuropathic pain (English)

1 reference

16 August 2017

0 references

Ian Gilron

1

1 reference

PubMed ID

17355217

16 August 2017

Terence J Coderre

series ordinal

2

1 reference

PubMed ID

17355217

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Expert Opinion on Emerging Drugs

16 August 2017

1 reference

16 August 2017

12

1 reference

16 August 2017

1

1 reference

16 August 2017

113-126

1 reference

Defining neuropathic pain

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The natural history of painful diabetic neuropathy--a 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The clinical picture of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

HIV-associated neuropathic pain: epidemiology, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Epidemiology of incident spinal fracture in a complete population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Neuropathic pain after traumatic spinal cord injury--relations to gender, spinal level, completeness, and age at the time of injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

NMDA receptors as targets for drug action in neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Glutamate receptors and nociception: implications for the drug treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Identification of MEK1 as a novel target for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Neurotrophin-3 antisense oligonucleotide attenuates nerve injury-induced Abeta-fibre sprouting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Down-regulation of GFRalpha-1 expression by antisense oligodeoxynucleotide aggravates thermal hyperalgesia in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.1.113

10.1517/14728214.12.1.113

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17355217